marketreportsupdates (108)

1
Antifungal Drugs Market To Reach USD 13.03
Billion By 2026
2
Market Size USD 11.61 billion in 2018, Market
Growth - CAGR of 1.4, Market Trends Increased
investments in RD for drug discovery
Market Summary
The global antifungal drugs market is expected to
reach USD 13.03 Billion by 2026, according to a
new report by Reports and Data. Antifungal drugs
are used to treat fungal infections. Rising
prevalence of fungal infections and fungal
diseases is one of the most significant factors
anticipated to boost the market demand in the
upcoming years.

• Further key findings from the report suggest
• Azoles held the largest market share of over 40
  in 2018 and is expected to witness the fastest
  growth rate of 1.6 in the forecast period. The
  growing demand of Azoles may be attributed to the
  ongoing development of novel antifungal drugs by
  making use of the azole group.
• Azoles are extensively used for the treatment of
  superficial and invasive fungal infections. The
  drug has fewer side-effects, less severe drug
  interactions, and enhanced absorption and
  distribution properties.
• Dermatophytosis held a market size of USD 2.79
  billion in 2018 and is estimated to grow at the
  fastest rate of 1.7 throughout the forecast
  period owing to the increasing prevalence of skin
  infections especially in children.

www.reportsanddata.com
3
Market Summary
Key Players
Key participants include Merck Co. Inc.,
Novartis AG, Pfizer Inc., Bayer AG, Enzon
Pharmaceuticals Inc., GlaxoSmithKline PLC,
Abbott, Sigma-Aldrich, Glenmark Pharmaceuticals,
and Astellas Pharma Inc. among others.
Segmentation
Drug Class Outlook (Revenue, USD Million
2016-2026) Azoles Voriconazole (Vfend) Posaconazol
e (Noxafil) Clotrimazole (Canesten) Isavuconazole
(CRESEMBA) Others Echinacandins Caspofungin
(Cancidas) Micafungin (Mycamine/ Funguard) Others
To look at the PDF Sample Report and get 30
minutes of a free consultation _at_
https//www.reportsanddata.com/sample-enquiry-form
/1399
www.reportsanddata.com
4
Market Summary
Dosage Form Outlook (Revenue, USD Million
2016-2026) Liquid or Spray Shampoo Gels Injections
Pills Creams Indication Outlook (Revenue, USD
Million 2016-2026) Candidiasis Dermatophytosis As
pergillosis Others Distribution Channel Outlook
(Revenue, USD Million 2016-2026) Hospitals
Pharmacies Specialty Clinics Retail
Pharmacies Online Pharmacies
Grab Your Report at an Impressive Discount!
Please Click Here _at_ https//www.reportsanddata.c
om/discount-enquiry-form/1399
www.reportsanddata.com
5
The report emphasizes the following key
questions
Q.1.What are the most lucrative and promising
growth prospects for the market? Q.2.Which
sectors are expected to deliver a high growth
rate and which industry aspects come into play in
this advancement? Q.3.Which geographies are
estimated to exhibit the highest growth and the
underlying causes? Q.4.Which factors are
impacting the future of the market and what are
the driving factors? Q.5.What are the hurdles
and challenges curtailing the industrys growth
in the forecast period?
www.reportsanddata.com
6
About Us
Reports and Data is a market research and
consulting company that provides syndicated
research reports, customized research reports,
and consulting services. Our solutions purely
focus on your purpose to locate, target and
analyze consumer behavior shifts across
demographics, across industries and help clients
make a smarter business decision. We offer market
intelligence studies ensuring relevant and
fact-based research across a multiple industries
including Healthcare, Technology, Chemicals,
Power, and Energy. We consistently update our
research offerings to ensure our clients are
aware about the latest trends existent in the
market. Reports and Data has a strong base of
experienced analysts from varied areas of
expertise.
Contact Us John Watson Head of Business
Development Reports And Data Web
www.reportsanddata.com Direct Line
1-212-710-1370 E-mail sales_at_reportsanddata.com